Skip to main content
. 2016 Mar 2;2016(3):CD008274. doi: 10.1002/14651858.CD008274.pub3

Cohen 1991.

Methods DESIGN: parallel, cluster randomised, no information on blinding
 DURATION: 12 months
 NUMBER OF STUDY CENTRES: 1
 COUNTRY OF PUBLICATION: USA
 SPONSOR: ‐
Participants WHO PARTICIPATED: hypertensive and obese patients stratified by residents (residents not patients were randomised to intervention or control group)
 SETTING: model family practice unit (Pittsburgh)
MAIN INCLUSION CRITERIA:
 age 20 to 75 years; BMI ≥ 28 kg/m(men); ≥ 27 kg/m(women); SBP ≥ 140 mm Hg, DBP ≥ 90 mm Hg in 2 or more readings
MAIN EXCLUSION CRITERIA:
 not described in detail
NUMBER (educationally oriented intervention vs standard consultation): 15 vs 15 patients were randomised (10 vs 8 physicians); 15 vs 15 were analysed
GENERAL BASELINE CHARACTERISTICS (dietary intervention vs no dietary intervention):
 MEAN AGE [YEARS]: 59 vs 60
 GENDER [% MALE]: 27 vs 27
 NATIONALITY: ‐
 ETHNICITY: ‐
 WEIGHT [kg]: 92 vs 92
 BODY MASS INDEX [kg/m2]: 34 vs 34
 SITTING SYSTOLIC BLOOD PRESSURE [mm Hg]: ‐
 SITTING DIASTOLIC BLOOD PRESSURE [mm Hg]: ‐
 MEAN ARTERIAL BLOOD PRESSURE [mm Hg]: 106 vs 106
 COMORBID CONDITIONS: obesity
 ANTIHYPERTENSIVE TREATMENT: (number of medications 1.6 vs 1.2)
 DURATION OF HYPERTENSION: ‐
SUBGROUP ANALYSES: 
 weight losers vs weight gainer
Interventions LENGTH OF FOLLOW‐UP: 12 months
DIETARY INTERVENTION: physicians (n = 10) were taught by a behavioural psychologist; the goal of the dietary advice was to reduce the caloric content of the diet without radically changing the patient's lifestyle; monthly patient consultations and reviewing diet history sheet; the suggested diets were not specifically intended to be salt reducing
 NO DIETARY INTERVENTION: physicians (n = 8) received no special instructions or materials; the patients continued to be treated with their usual care
Outcomes PRIMARY OUTCOMES:
1. MORTALITY: ‐
 2. CARDIOVASCULAR MORBIDITY: ‐
 3. ADVERSE EVENTS: ‐ 
SECONDARY OUTCOMES:
1. CHANGES IN SYSTOLIC BLOOD PRESSURE [mm Hg]: ‐
 2. CHANGES IN DIASTOLIC BLOOD PRESSURE [mm Hg]: ‐
 3. BODY WEIGHT [kg]:
 Definition: body weight change from baseline to 6 months, from baseline to 12 months, and from 6 months to 12 months
ADDITIONAL OUTCOMES MEASURED IN THE STUDY: 
 1. Mean arterial blood pressure change in mm Hg
 2. Change in number of antihypertensive medications
 3. Number of visits
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Comment: No details on generation sequence are provided
 Quote: "The residents were stratified by residency year and randomly assigned to either control or experimental groups. ... The experimental or control status of a patient was determined by the status of the physician, and great care was taken to avoid contamination."
Allocation concealment (selection bias) Unclear risk Comment: Method of concealment is not described
Blinding (performance bias and detection bias) 
 All outcomes High risk Comments: No description of randomisation; since the physicians assigned to the experimental group were taught about the weight‐reducing programme, knowledge of the allocation intervention was not prevented during study
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk WITHDRAWALS: none
 REASONS/DESCRIPTIONS: ‐
Selective reporting (reporting bias) Unclear risk Comment: No primary and secondary outcomes were defined
Other bias High risk Comments:
 1. Lack of information of randomisation
 2. Stratified randomisation of investigators instead of patients with very small cluster size